Podcast thumbnail for Young Lung Cancer Initiative Podcast

Young Lung Cancer Initiative Podcast

Claim This Podcast

by Young Lung Cancer Initiative

5.0(1 reviews)
24 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Overview

<p>The Young Lung Cancer Initiative Podcast brings together patient stories, expert insight, education, and real community resources for people impacted by lung cancer.</p><p>You’ll hear honest conversations with patients living with this disease.<br />You’ll hear researchers and oncologists break down evolving science.<br />You’ll hear practical discussions about treatment decisions, side effects, insurance barriers, mental health, caregiving, and quality of life.</p><p>We also share community based support resources designed specifically for young people and people without smoking history navigating lung cancer.</p><p>This podcast centers the lived experience while staying grounded in evidence based medicine.</p><p>If you are a patient, caregiver, advocate, or clinician who wants deeper understanding of what lung cancer actually looks like in real life, this is for you.</p><p>New episodes released regularly.</p>

Language

🇺🇲

Publishing Since

2/20/2026

1 verified contact email on file for Young Lung Cancer Initiative Podcast

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for HER2 Lung Cancer Resistance and Emerging Research With Dr. Kyle Concannon | Ep. 3 of 3

June 25, 2026

HER2 Lung Cancer Resistance and Emerging Research With Dr. Kyle Concannon | Ep. 3 of 3

<p>In Part 3 of our HER2-driven lung cancer series, Leah Phillips and thoracic medical oncologist Dr. Kyle Concannon (UC Health, University of Colorado) tackle the harder questions. They get into what resistance actually means, the difference between on-target and off-target resistance, why a cancer can sometimes transform into a different type entirely, and the emerging research and combination approaches being studied for HER2 lung cancer patients.</p><p>This is a conversation many patients will eventually need to have. The research is moving fast and there is real reason for hope.</p><p>Thanks to Boehringer Ingelheim for supporting this series. YLCI retains full editorial control.</p><p>This content is for informational purposes only and is not medical advice. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.</p>

Episode thumbnail for HER2 Lung Cancer Treatment & Monitoring With Dr. Kyle Concannon | Ep. 2 of 3

June 25, 2026

HER2 Lung Cancer Treatment & Monitoring With Dr. Kyle Concannon | Ep. 2 of 3

<p>Once you know you have HER2 lung cancer, what comes next? In Part 2 of our HER2-driven lung cancer series, Leah Phillips and thoracic medical oncologist Dr. Kyle Concannon (UC Health, University of Colorado) walk through what treatment actually looks like. They cover how first-line decisions are made for early versus advanced disease, where HER2-targeted therapies fit in, how doctors tell whether a treatment is working, what brain monitoring looks like, and what a progression conversation involves.</p><p>Whether you're newly diagnosed or supporting someone through treatment, this episode will help you walk into your next oncology appointment more prepared.</p><p>Thanks to Boehringer Ingelheim for supporting this series. </p><p>YLCI retains full editorial control.</p><p>This content is for informational purposes only and is not medical advice. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.</p>

Episode thumbnail for HER2 Lung Cancer Explained: Overexpression, Amplification &  Exon 20 Mutation | Dr. Concannon | Pt 1

June 17, 2026

HER2 Lung Cancer Explained: Overexpression, Amplification & Exon 20 Mutation | Dr. Concannon | Pt 1

<p>n lung cancer, HER2 can mean different things.<br />In Part 1 of our HER2-driven lung cancer series, Leah Phillips sits down with thoracic medical oncologist Dr. Kyle Concannon (UC Health, University of Colorado) to cover the basics: what a HER2 alteration actually is, the difference between overexpression, amplification, and the exon 20 insertion mutation, why the type matters for treatment, and why next-generation sequencing at diagnosis is non-negotiable.<br />This is Part 1 of 3. Parts 2 and 3 cover treatment and monitoring, then resistance and emerging research.<br /><br />About Dr. Kyle Concannon: Assistant Professor of Medicine-Medical Oncology at the University of Colorado and a thoracic medical oncologist at UCHealth University of Colorado Hospital. Trained as a physician-scientist at MD Anderson, his lab studies why oncogene-driven lung cancers (EGFR, HER2, ALK, ROS1) stop responding to therapy and how to overcome that resistance. He also co-hosts The <a rel="noopener noreferrer nofollow" href="https://studio.youtube.com/channel/UCFJwUDDzRTkv81Nq8PEuJ3A" target="_blank"> @crackingcancer podcast </a><br /><a rel="noopener noreferrer nofollow" href="https://som.cuanschutz.edu/Profiles/Faculty/Profile/40545" target="_blank">https://som.cuanschutz.edu/Profiles/Faculty/Profile/40545</a><br /><br />This series is proudly sponsored by Boehringer Ingelheim.<br /><br />This is educational content. Not medical advice. Always talk to your own care team about your specific situation.</p>

24 total episodes available

Deep-dive analytics for Young Lung Cancer Initiative Podcast

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Young Lung Cancer Initiative Podcast?
<p>The Young Lung Cancer Initiative Podcast brings together patient stories, expert insight, education, and real community resources for people impacted by lung cancer.</p><p>You’ll hear honest conversations with patients living with this disease.<br />You’ll hear researchers and oncologists break down evolving science.<br />You’ll hear practical discussions about treatment decisions, side effects, insurance barriers, mental health, caregiving, and quality of life.</p><p>We also share community based support resources designed specifically for young people and people without smoking history navigating lung cancer.</p><p>This podcast centers the lived experience while staying grounded in evidence based medicine.</p><p>If you are a patient, caregiver, advocate, or clinician who wants deeper understanding of what lung cancer actually looks like in real life, this is for you.</p><p>New episodes released regularly.</p>
How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.